4//SEC Filing
Stelmakh Edward 4
Accession 0001628280-24-042848
CIK 0001448431other
Filed
Oct 14, 8:00 PM ET
Accepted
Oct 15, 4:53 PM ET
Size
8.9 KB
Accession
0001628280-24-042848
Insider Transaction Report
Form 4
OptimizeRx CorpOPRX
Stelmakh Edward
CFO/COO
Transactions
- Exercise/Conversion
Common Stock
2024-10-11+8,222→ 35,432 total - Tax Payment
Common Stock
2024-10-11$6.63/sh−2,066$13,698→ 33,366 total - Exercise/Conversion
Restricted Stock Units
2024-10-11−8,222→ 0 total→ Common Stock (8,222 underlying)
Footnotes (3)
- [F1]Restricted stock units convert into common stock on a one-for-one basis.
- [F2]These shares were withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations. Such withholding is treated as a disposition of securities under Section 16 of the Securities Exchange Act of 1934, as amended.
- [F3]The restricted stock units vest in three equal annual installments beginning October 11, 2022, the first anniversary of the grant date.
Documents
Issuer
OptimizeRx Corp
CIK 0001448431
Entity typeother
Related Parties
1- filerCIK 0001887046
Filing Metadata
- Form type
- 4
- Filed
- Oct 14, 8:00 PM ET
- Accepted
- Oct 15, 4:53 PM ET
- Size
- 8.9 KB